| 1578607 | COARD5_H | Coronary artery disease susceptibility QTL 5 (human) | 2.63 | .0002 | Coronary artery disease susceptibility | | 2 | 198714649 | 240901754 | Human | n/a | region | qtl |
| 2316066 | GLUCO201_H | Glucose level QTL 201 (human) | | .008 | Glucose level | | 2 | 209017112 | 235017112 | Human | n/a | region | qtl |
| 2293468 | PRSTS292_H | Prostate tumor susceptibility QTL 292 (human) | | .013 | Prostate tumor susceptibility | | 2 | 211696915 | 237696915 | Human | n/a | region | qtl |
| 2293478 | PRSTS301_H | Prostate tumor susceptibility QTL 301 (human) | | .002 | Prostate tumor susceptibility | | 2 | 211696915 | 237696915 | Human | n/a | region | qtl |
| 2293483 | PRSTS283_H | Prostate tumor susceptibility QTL 283 (human) | | | Prostate tumor susceptibility | | 2 | 211696915 | 237696915 | Human | n/a | region | qtl |
| 1331635 | COPD19_H | Chronic obstructive pulmonary disease QTL 19 (human) | 4.12 | | Chronic airflow obstruction | FEV1/FVC ratio | 2 | 214579907 | 238078645 | Human | n/a | region | qtl |
| 2289332 | BW376_H | Body weight QTL 376 (human) | 1.87 | .00168 | Body fat amount | abdominal | 2 | 214629769 | 240629769 | Human | n/a | region | qtl |
| 1643044 | BW151_H | Body weight QTL 151 (human) | | .0045 | Body fat amount | percent body fat | 2 | 216180297 | 242180297 | Human | n/a | region | qtl |
| 1298412 | RA1_H | Rheumatoid arthritis QTL 1 (human) | | .0141 | Joint/bone inflammation | rheumatoid arthritis | 1 | 217683765 | 243062293 | Human | n/a | region | qtl |
| 2315762 | GLUCO151_H | Glucose level QTL 151 (human) | 1.26 | .0079 | Glucose level | | 2 | 217683765 | 243062293 | Human | n/a | region | qtl |
| 2289209 | BW347_H | Body weight QTL 347 (human) | | .0123 | Body fat amount | percent fat | 2 | 218172688 | 243062293 | Human | n/a | region | qtl |
| 1643566 | GLUCO16_H | Glucose level QTL 16 (human) | .61 | .047 | Glucose level | non-insulin-dependent | 2 | 219206386 | 243062293 | Human | n/a | region | qtl |
| 2292834 | PRSTS26_H | Prostate tumor susceptibility QTL 26 (human) | | | Prostate tumor susceptibility | early onset | 2 | 219206386 | 243062293 | Human | n/a | region | qtl |
| 2289437 | BW401_H | Body weight QTL 401 (human) | 1.95 | | Body fat amount | percent fat | 2 | 220707942 | 243062293 | Human | n/a | region | qtl |
| 1643501 | BW261_H | Body weight QTL 261 (human) | 1.5 | .00482 | Body weight | body mass index | 2 | 220950848 | 243062293 | Human | n/a | region | qtl |
| 2315056 | GLUCO134_H | Glucose level QTL 134 (human) | 2.18 | | Glucose level | | 2 | 222777148 | 243062293 | Human | n/a | region | qtl |
| 1559407 | SCL113_H | Serum cholesterol level QTL 113 (human) | 2.31 | | Lipid level | LDL-HDL ratio | 2 | 224235556 | 243062293 | Human | n/a | region | qtl |
| 2302776 | MAMTS12_H | Mammary tumor susceptibility QTL 12 (human) | | .046 | Mammary tumor susceptibility | | 2 | 224235556 | 243062293 | Human | n/a | region | qtl |
| 2289589 | BW465_H | Body weight QTL 465 (human) | 2.4 | | Body weight | lean mass | 2 | 227293057 | 237235700 | Human | n/a | region | qtl |
| 2315772 | GLUCO146_H | Glucose level QTL 146 (human) | 3.03 | .002 | Glucose level | | 2 | 228168147 | 243062293 | Human | n/a | region | qtl |
| 1358856 | MULTSCL17_H | Multiple sclerosis susceptibility QTL 17 (human) | | | Multiple sclerosis susceptibility | | 2 | 228739542 | 243062293 | Human | n/a | region | qtl |
| 2315054 | GLUCO132_H | Glucose level QTL 132 (human) | 1.97 | | Glucose level | | 2 | 229853452 | 243062293 | Human | n/a | region | qtl |
| 2315066 | GLUCO131_H | Glucose level QTL 131 (human) | 3.19 | .00058 | Glucose level | | 2 | 229853452 | 243062293 | Human | n/a | region | qtl |
| 2293463 | PRSTS293_H | Prostate tumor susceptibility QTL 293 (human) | | .012 | Prostate tumor susceptibility | | 2 | 232206264 | 238078645 | Human | n/a | region | qtl |
| 2315804 | GLUCO166_H | Glucose level QTL 166 (human) | 1.87 | .0017 | Glucose level | | 2 | 233707822 | 237235700 | Human | n/a | region | qtl |